NCT06645782

Brief Summary

The overall goal of this clinical trial is to: a) explore the feasibility, acceptability, and participant experiences with the group version of CF-CBT; b) examine the effectiveness of the virtual delivery of a group version of CF-CBT in reducing depression and anxiety symptoms, perceived stress, coping skills, and health related quality of life among adults with CF. The primary research questions is:

  • How feasible and acceptable (i.e., drop out, adherence, and satisfaction) is virtual, group CF-CBT? The secondary research questions is:
  • How will virtual, group CF-CBT affect depression and anxiety? The tertiary/other research questions are:
  • How will virtual, group CF-CBT affect perceived stress, coping skills, and health related quality of life?
  • What is the association between group cohesion and depression, anxiety, perceived stress, coping skills, and health related quality of life? Participants will:
  • Complete short demographic questionnaire regarding their personal and health information.
  • Complete questionnaires about symptoms of depression, anxiety, perceived stress, coping skills, and health related quality of life at pre- and post-program. An additional measure of treatment expectancy will be completed at pre-program only. At post-program only, measures of group cohesion and treatment satisfaction will be completed.
  • Complete the CF-CBT online mental health program over eight weeks.
  • Be invited to complete an interview about their experiences with the program. Primary outcomes will be compared to benchmark study of individual CF-CBT. Secondary outcomes (i.e., depression, anxiety) will be compared against themselves (i.e., pre- and post-group). Tertiary/other outcomes (i.e., perceived stress, coping skills, health related quality of life) will be compared against themselves (i.e., pre- and post-group). The associations between self-reported outcome measures and group cohesion will be analyzed by computing Pearson correlation coefficients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

October 11, 2024

Last Update Submit

April 27, 2026

Conditions

Keywords

Cystic FibrosisCognitive Behavioural TherapyGroup TherapyMental HealthInternet

Outcome Measures

Primary Outcomes (3)

  • Acceptability of virtual group CF-CBT.

    Determined by rates of program completion and program satisfaction.

    From recruitment to completion of treatment (8 weeks).

  • Feasibility of virtual, group CF-CBT.

    Determined by rates of participants recruitment (i.e., how many are interested, enroll) and rates of attendance.

    From recruitment to completion of treatment (8 weeks).

  • Participant scores on the Client Satisfaction Questionnaire (CSQ) at the end of 8 week treatment.

    The CSQ measures satisfaction with a received service on an 8-item scale with items reflecting how satisfied the individual was with the service they completed. Total scores can range from a minimum score of 8 to a maximum score of 32.

    Post-intervention (8 weeks)

Secondary Outcomes (2)

  • Change from baseline in the Patient Health Questionnaire-9 (PHQ-9) at the end of 8 week treatment.

    Baseline and post-intervention (8 weeks)

  • Change from baseline in the Generalized Anxiety Disorder-7 (GAD-7) at the end of 8 week treatment.

    Baseline and post-intervention (8 weeks)

Other Outcomes (4)

  • Change from baseline in the Perceived Stress Scale (PSS) at the end of 8 week treatment.

    Baseline and post-intervention (8 weeks)

  • Change from baseline in the CF coping self-efficacy scale (CF-CSE) at the end of 8 week treatment.

    Baseline and post-intervention (8 weeks)

  • Change from baseline in the Cystic Fibrosis Questionnaire - Revised (CFQ-R) at the end of 8 week treatment.

    Baseline and post-intervention (8 weeks)

  • +1 more other outcomes

Study Arms (1)

Virtual, group CF-CBT

EXPERIMENTAL
Behavioral: Virtual, Group CF-CBT

Interventions

Virtual, group CF-CBT is an online, tailored CBT program for adults diagnosed with CF. Participants will attend eight weekly sessions (90 minutes each) delivered online. The sessions include: Introduction to CBT; Relaxation Skills; Depression in CF: What Helps?; Adaptive Thinking Skills, Part 1; Adaptive Thinking Skills, Part 2; Taking Charge of My Health; Anxiety in CF: What Helps?; and Maintaining Positive Changes.

Virtual, group CF-CBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age.
  • Must speak and read in English.
  • Must have depression and/or anxiety scores in the mild to moderate range (as per the PHQ-9 and GAD-7) prior to study baseline.

You may not qualify if:

  • Those with suicidal intent (either with or without a plan).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St. Paul Hospital

Vancouver, British Columbia, Canada

Location

Royal Jubilee Hospital

Victoria, British Columbia, Canada

Location

MeSH Terms

Conditions

Cystic FibrosisPsychological Well-Being

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesPersonal SatisfactionBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 11, 2024

First Posted

October 17, 2024

Study Start

October 1, 2024

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

May 1, 2026

Record last verified: 2026-04

Locations